Invivyd (IVVD) Common Equity (2020 - 2025)

Invivyd (IVVD) posted Common Equity of $241.5 million for Q4 2025, up 159.53% on a QoQ basis from $93.1 million in Q3 2025, and up 257.63% year-over-year from $67.5 million in Q4 2024.

Invivyd (IVVD) Common Equity (2020 - 2025) Analysis & Trends

Invivyd's Common Equity history runs 6 years deep, the most recent figure standing at $241.5 million for Q4 2025.

  • Quarterly Common Equity rose 257.63% year-over-year to $241.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $241.5 million (up 257.63% YoY) and the FY2025 annual result came in at $241.5 million, up 257.63% from the prior year.
  • Common Equity was $241.5 million for Q4 2025 at Invivyd, up from $93.1 million in the prior quarter.
  • Across five years, Common Equity topped out at $633.2 million in Q3 2021 and bottomed at -$144.6 million in Q2 2021.
  • A 5-year average of $224.2 million and a median of $210.0 million in 2024 frame the typical range for Common Equity.
  • Annual changes were most pronounced in 2021 — Common Equity surged 955.21% — and 2025, when it tumbled 69.66%.
  • Invivyd's Common Equity stood at $558.0 million in 2021, then plunged by 36.21% to $356.0 million in 2022, then sank by 50.15% to $177.5 million in 2023, then slumped by 61.94% to $67.5 million in 2024, then soared by 257.63% to $241.5 million in 2025.
  • Business Quant data shows IVVD's Common Equity at $241.5 million in Q4 2025, $93.1 million in Q3 2025, and $42.8 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 251.12 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -98.34 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 14.38 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.76 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - 795.79 Mn
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 1.50 Bn
10 Invivyd 104.07 Mn -122.62 Mn 16.07 Mn 241.54 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 241.54 Mn
Sep 30, 2025 93.07 Mn
Jun 30, 2025 42.79 Mn
Mar 31, 2025 54.15 Mn
Dec 31, 2024 67.54 Mn
Sep 30, 2024 83.16 Mn
Jun 30, 2024 140.64 Mn
Mar 31, 2024 178.50 Mn
Dec 31, 2023 177.47 Mn
Sep 30, 2023 246.50 Mn
Jun 30, 2023 281.56 Mn
Mar 31, 2023 326.75 Mn
Dec 31, 2022 355.97 Mn
Sep 30, 2022 377.44 Mn
Jun 30, 2022 414.84 Mn
Mar 31, 2022 459.39 Mn
Dec 31, 2021 558.02 Mn
Sep 30, 2021 633.21 Mn
Jun 30, 2021 -144.62 Mn
Mar 31, 2021 -103.36 Mn